Celltrion ramps up capacity with W1.2tr Songdo investment

Celltrion said Tuesday it will invest 1.23 trillion won ($820 million) to build two new plants in Songdo, Incheon, bolstering its capacity by 180,000 liters amid the increasing global demand. According to the Korean biosimilar producer, the investment will be carried out in phases through 2030 to support the company’s production and supply of next-generation biosimilar and drug candidates while expanding its contract manufacturing organization, or CMO, business worldwide. Celltrion also announce

By The Korea Herald